TREM2 and neoplasm: In non-small cell lung cancer (NSCLC) cells, TREM2+ DCs are heavily infiltrated in cancerous tissues and can inhibit T cell proliferation by secreting large amounts of IL-10 (24), promoting tumor growth (Figure 1).